Mushroom Recall Sparks Warning After Person Dies

The U.S. Food and Drug Administration (FDA) is urging people not to consume or purchase any Diamond Shruumz microdosing products from California-based Prophet Premium Blends after learning that the recalled product, which has been linked to dozens of illnesses and one potential death, is still available in stores nationwide.

All Diamond Shruumz products, including the microdosing chocolate bars, infused cones and micro-dose and meda-dose/extreme gummies, were recalled in June. However, in an update issued on Tuesday, the FDA warned that the recalled products were still available for sale at smoke and vape shops, as well as other retailers, such as those that sell cannabidiol (CBD) and delta-8 tetrahydrocannabinol (THC) products.

Newsweek previously reported that the products were recalled because they contain Muscimol, a chemical found in mushrooms of the genus Amanita, which could be a potential cause of symptoms consistent with those observed in persons who became ill after eating Diamond Shruumz products.

NBC 4 reported that Diamond Shruumz described its products as "the future of microdosing" on its website and advertised that they included ingredients such as Lion's mane, Reishi and Chaga mushrooms, as well as adaptogens. However, Newsweek was unable to access Prophet Premium Blends' website as of Wednesday evening.

Newsweek reached out to Prophet Premium Blends by phone for comment.

In its update, the FDA reiterated that Diamond Shruumz products should not be sold anywhere.

"All Diamond Shruumz-brand products have been recalled and should not be sold. Consumers should not purchase any Diamond Shruumz-brand products," the alert said.

As of Monday, 69 illnesses have been reported across 28 states in regard to consuming the product. Sixty of those people reported seeking medical care, the FDA said, and 36 were hospitalized. The last illness onset began on Monday, the FDA said.

States with people reporting illness include Alabama, Arizona, California, Colorado, Florida, Georgia, Indiana, Iowa, Kentucky, Maryland, Minnesota, Missouri, Montana, Nevada, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Virginia and Washington.

"There is one potentially associated death under investigation," the alert said.

According to the alert, people who became ill after consuming the product experienced a variety of severe symptoms. Symptoms included seizures, central nervous system depression such as loss of consciousness, confusion, sleepiness, agitation, abnormal heart rates, hyper/hypotension, nausea and vomiting.

"FDA is working with the National Association of Convenience Stores and the National Smoke Shop Association to increase awareness of the recall," the alert said. "If you have seen a store continuing to sell recalled Diamond Shruumz-brand products, you can report this information to FDA."

Mushroom Recall Sparks Warning After Person Dies
A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. The FDA is urging people not to purchase or consume Diamond Shruumz... Getty

About the writer


Anna Skinner is a Newsweek senior reporter based in Indianapolis. Her focus is reporting on the climate, environment and weather ... Read more

To read how Newsweek uses AI as a newsroom tool, Click here.
Newsweek cover
  • Newsweek magazine delivered to your door
  • Newsweek Voices: Diverse audio opinions
  • Enjoy ad-free browsing on Newsweek.com
  • Comment on articles
  • Newsweek app updates on-the-go
Newsweek cover
  • Newsweek Voices: Diverse audio opinions
  • Enjoy ad-free browsing on Newsweek.com
  • Comment on articles
  • Newsweek app updates on-the-go